The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma

Abstract

Le Ren, Yue Yu Department of Gastroenterology, Affiliated Provincial Hospital, Anhui Medical University, Hefei, China Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains a very challenging malignancy with late presentation, metastatic potential, chemoresistance, and poor prognosis. Therefore, there is an urgent need for novel diagnostic and prognostic biomarkers. miRNAs are small noncoding RNAs that regulate the expression of multitude number of genes. Aberrant expression of miRNAs has been linked to the development of various malignancies, including PDAC. A series of miRNAs have been defined as holding promise for early diagnostics, as indicators of therapy resistance, and even as markers for prognosis in PDAC patients. In this review, we summarize the current knowledge on the role of miRNAs in diagnosis, chemoresistance, and prognosis in PDAC patients. Keywords: pancreatic ductal adenocarcinoma, miRNA, diagnosis, prognosis, chemoresistance

Keywords

• Pancreatic ductal adenocarcinoma
• Micro-RNA
• Diagnosis
• Prognosis
• Chemoresistance